Nav: Home

The Lancet Oncology: Globally, more than 11 million years of healthy life lost due to childhood cancer in 2017

July 29, 2019

  • Study is first analysis to quantify the impact of childhood cancer in terms of years of healthy life lost to ill-health and premature death
  • Collectively, childhood cancers are the 6th biggest contributor to total cancer burden worldwide after adult cancers of the lung, liver, stomach, colon, and breast; and the 9th leading cause of childhood disease burden globally
  • India, China, Nigeria, Pakistan, Indonesia, and the USA face the largest burden of childhood cancer among countries with the highest population of children
  • Lack of diagnosis and access to healthcare and a younger population are responsible for disproportionately large childhood cancer burden in many of the poorest countries
While the number of new cancer cases in children and adolescents (aged 0-19 years) is relatively low at around 416,500 globally in 2017, treatment-related ill-health and disability and fatal cancer are estimated to cause around 11.5 million years of healthy life lost globally every year, according to the first Global Burden of Disease Study (GBD) to assess childhood and adolescent cancer burden in 195 countries in 2017, published in The Lancet Oncology journal.

Children in the poorest countries face a disproportionately high cancer burden--contributing over 82% of the global childhood cancer burden--equivalent to almost 9.5 million years of healthy life lost in 2017. Most (97%) of this global burden is related to premature death, with around 3% due to impaired quality of life.

For the first time, researchers provide a complete picture of the global and regional burden of childhood cancer beyond incidence, mortality, and survival. The study estimates the number of years of healthy life that children and adolescents with cancer have lost due to illness, disability, and premature death--a measurement known as disability-adjusted life years (DALYs). One DALY is equivalent to one year of healthy life lost. However, disability in childhood cancer survivors was limited to the first 10 years after cancer diagnosis, rather than across the whole life course, so the global burden of DALYs associated with childhood cancer is probably underestimated, researchers say.

"By assessing the global burden of childhood cancer through the lens of disability-adjusted life-years, we can more comprehensively understand the devastating impact of cancer on children globally," says Dr Lisa Force from St Jude Children's Research Hospital in the USA, who led the research in collaboration with the Institute for Health Metrics and Evaluation. "Our findings are an important first step in establishing that childhood cancer has a role in frameworks that address global oncology and global child health." [1]

Children with cancer who live in high-income countries tend to have good survival, with around 80% surviving 5 years after diagnosis. But these improvements have not translated to most low- and middle-income countries (LMICs), where survival is approximately 35-40%, but some estimates suggest it could be as 20%. Around 90% of children at risk of developing cancer live in LMICs.

"Improving childhood cancer survival will require considerable planning by policy makers to ensure well-functioning health systems capable of early diagnosis and treatment," says Dr Force. "Estimating the years of healthy life children have lost due to cancer allows policy makers to compare the lifelong implications of childhood cancer with other diseases, potentially helping them determine the most effective way to spend limited resources and identify high-impact cancer-control planning decisions". [1]

In the study, global and regional estimates were analysed using socio-demographic Index (SDI), a measure based on rates of education, fertility, and income. Countries with high SDI have high levels of income and education and low fertility, whereas countries with low SDI have low levels of income and education and high fertility.

The study reveals striking inequities in childhood cancer burden between high and low SDI countries (table). High and high-middle SDI countries accounted for about 35% (147,300) of new cases of childhood cancer in 2017, but only 18% of DALYs (around 2 million years of healthy life lost), whereas low-middle and low SDI countries with 38% of global incidence (159,600 new cases) accounted for 60% of DALYs (almost 7 million years of healthy life lost).

Moreover, the research finds that childhood cancers are a major cause of global disease burden compared with both adult cancers and other childhood diseases. In 2017, childhood cancers were the sixth leading cause of years of healthy life lost out of all cancers globally (11.5 million), only lower than the burden from adult cancers of the lung (41 million), liver (21 million), stomach (19 million), colon (19 million), and breast (18 million). In low and middle SDI countries, childhood cancers were the leading cause of DALYs, higher than the burden attributable to any single adult cancer type (figure 6A).

The study puts the annual toll of childhood cancer at over 11.5 million years of healthy life lost in 2017. This compares with around 37 million years of healthy life lost globally due to malaria, and 7.6 million from tuberculosis (figure 6B). In 2017, childhood cancer was among the top four biggest contributors to the burden of general diseases of childhood in middle and high-middle SDI countries, ranking higher than malaria and HIV/AIDS.

While four of the five countries with the highest childhood cancer burden were in Asia and Oceania (India, China, Pakistan, and Indonesia), the USA had the sixth largest burden in 2017, and sub-Saharan Africa had the biggest DALY burden for more childhood cancer types than any other region. (figure 4).

Cancers of the blood (leukaemias) were the main contributors to overall DALYs, accounting for 34% of the total childhood cancer burden worldwide, followed by brain and nervous system cancers (18%). In 2017, the proportion of both leukaemia and brain cancer burden differed by almost 3 times between regions. The proportional burden of leukaemias was highest in central and Andean Latin America (49% of all childhood cancers) and the greatest absolute burden was in south Asia (954,000 DALYs).

The authors highlight the fact that mechanisms for addressing cancer burden in adults, which focus on risk-reduction strategies and screening interventions, are not as relevant to childhood cancers given that childhood cancers generally progress rapidly, are not amenable to screening programmes which aim to identify pre-cancerous growths, and are fatal without swift diagnosis and treatment. This emphasizes the crucial role early diagnosis and treatment will play in order to reduce the global burden of childhood cancer.

Despite these important findings, the methodology used to estimate childhood cancer burden has several limitations that need to be addressed, say the authors. While the study uses the best available data, predictions are constrained by a lack of high-quality cancer data, particularly in developing countries--highlighting the need to expand the quality and quantity of population-based cancer registration systems and to include data from paediatric-specific cancer registries. They also note that the current anatomical site-based system of reporting adult cancer leaves over 26% of the childhood cancer burden (3 million DALYs) linked to cancers that are uncategorised, a challenging category for policy, financial, and clinical decision making.

In an accompanying editorial, the editors of The Lancet Child & Adolescent Health journal write: "The universal language of data offers a substantial opportunity to those fighting the global burden of childhood cancer. Analysis of the DALY burden by individual country and cancer subtype shows the significant need for investment in data capture. Quality data collection and standardised reporting are crucial early strides towards better care provision for children with cancer in LMICs. Capture of national childhood cancer data can guide investments in training of specialists to ensure earlier diagnoses, providing equitable access to medicines, reducing deaths, and improving survivorship care and quality of life."

Writing in a linked Comment, Charles Stiller from Public Health England, UK, discusses what can be done to mitigate or even reduce the global burden of childhood and adolescent cancer. He writes: "Early diagnosis can bring substantial reduction in mortality and long-term morbidity. Although gains from early diagnosis should be greatest in lower-resource countries, where too many cases are diagnosed at a late stage, they should be felt even in affluent countries, notably for people with low-grade brain tumours, survivors of which bear a considerable burden of disability. For the benefits of early diagnosis to be fully realised worldwide, it must be accompanied by improved diagnostic and treatment facilities with universal access. International collaboration will be an essential component of the necessary capacity building. It is to be hoped that the present study will help to stimulate the necessary improvements, and future iterations can monitor their success."
-end-
NOTES TO EDITORS

This study was funded by the Bill & Melinda Gates Foundation, American Lebanese Syrian Associated Charities (ALSAC), and St. Baldrick's Foundation. It was conducted by researchers from St Jude Children's Research Hospital, Memphis, TN, USA and University of Washington, Seattle, WA, USA.

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf if you have any questions or feedback, please contact The Lancet press office pressoffice@lancet.com

[1] Quotes direct from author and cannot be found in text of Article.

Peer-reviewed / Observational and modelling study / People

The Lancet

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.